Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Charles River buys Argenta and BioFocus from Galapagos for €129mm plus earn-outs

Executive Summary

Charles River Laboratories International Inc. acquired Galapagos NV’s drug discovery service providers Argenta Discovery Ltd. and BioFocus DPI for a total of €129mm ($179mm) in cash up front, plus up to another €5mm in performance-based earn-outs.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
      • Bioinformatics
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Includes Earnout
    • Intra-Biotech Deal
    • Includes Contract
    • Acquisition of Private Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register